The Standard Group Plc is a multi-media organization with investments in media
platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national
and international interest.
Christine Mbali had high expectations when she started treatment for drug-resistant Tuberculosis in December 2017. For weeks before her diagnosis, a series of alarming symptoms had frightened her.
“A visit to the hospital led to my diagnosis with drug-resistant Tuberculosis.” But as she soon discovered, the Injectable Regimen [FM1], the TB treatment she was put on at the time, came with its fair share of challenges. She had to visit the clinic daily for some pills and an injection.
“I began my nine-month treatment with a prescription of one injection and 18 pills daily.”
Facts First
This story continues on The Standard INSiDER. Subscribe now for unfiltered journalism that holds power to account.
Already have an account? Login
join